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 Lysyl Oxidase (LOX) is a key enzyme for the production of collagen cross-links 
in connective tissue development. This study investigated the phenotypic effects of 
mouse Lox deletion using Cre-recombinase technology driven by the promoter of the 
osteoblast specific hormone osteocalcin. 6 Female Ocn-cre-/-, Lox fl/fl; 6 female Ocn-
cre+/-, Loxfl/fl; 6 male Ocn-cre-/-, Loxfl/fl, and 6 male Ocn-cre+/-, Loxfl/fl were sacrificed at 
13-weeks for µCT and histological analysis. µCT data revealed statistically significant 
reduction in Bone Volume/Total Volume (BV/TV) (P<.003), Connective Tissue Density 
(ConnD) (P<.012), Bone Mineral Density (BMD) (P<.001), and Structural Model Index 
(SMI) (P<.004). Male 13-week old Ocn-cre+/-, Loxfl/fl mice showed no statistically 
significant differences in any parameters analyzed. Histological analysis showed 
decreases in the number of chondrocytes per column in the cre+/- female and male mice. 
The largest differences in number of chondrocytes per column were found in female 
cre+/- mice. Thus, osteoblast specific knockout of Lox appeared to show phenotypic 
affects more strongly in females rather than male mice. Further analysis into Lox 
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Lysyl Oxidase (LOX) is a key copper dependent amine oxidase enzyme that 
functions in the final steps of collagen and elastin biosynthesis (1, 2). Extracellularly, 
LOX catalyzes the oxidation reaction of lysine and hydroxylysine side chains located on 
the telopeptide regions of fibrillar procollagens to allysine and hydroxyallysine, 
respectively (3). These highly reactive aldehyde residues self-coalesce into normal 
immature and mature cross-links in collagen fibrils (4). From there, the collagen 
mineralizes and forms the fundamental structure of bone.  
The biosynthesis of Lox has been explored using rat vascular smooth muscle cells 
by Trackman and others. Lox begins as a 46 kDa preproprotein consisting of three 
domains: an N-terminal signal peptide, a propeptide, and a catalytic domain (2, 3, 5). 
Inside the cell, the signal sequence is removed and the propeptide domain is N-
glycosylated for travel through the Golgi, and is subsequently released outside the cell as 
an inactive protein (5). The 50 kDa pro-protein is cleaved yielding the active enzyme by 
BMP-1, and two other procollagen C-proteinases (6).  
There are five isoforms of lysyl oxidase, including LOX and lysyl oxidase-like 1-
4 (LOXL1-LOXL4). LOX and LOXL1-LOXL4 have a conserved C-terminal domain, but 
differ in that LOXL2-LOXL4 have four scavenger receptor cysteine rich domains; LOX 
and LOXL1 do not have such cysteine-rich domains. Additionally, more investigation 
has been done explaining the expanded role of these isoforms in cases of fibrosis, 
cancers, and diabetic complications (3), thus suggesting that LOX and its isoforms are 





LOXL1 has sex-specific bone abnormalities in Loxl1 knockout mice (1, 7). Furthermore, 
LOX and its isoforms have a paradoxical role when it comes to their role in cancer (8-
10). Some studies have shown that Lox plays a more tumor promoting role, while the 
Lox pro-peptide, cleaved off during biosynthesis, serves a protective role (10-12). 
However, it is widely considered that LOX is able to alter the tumor microenvironment, 
and is a key marker in cancer detection and a potential target in cancer therapy (8). In a 
recent study the mechanism by which LOXL2 promotes cancer progression and 
development was elucidated. The authors found tumor cell LOXL2 stimulates oral 
fibroblasts by oxidizing the PDGFR𝛃 receptor on oral fibroblasts, resulting in increased 
cell proliferation (13). Therefore, LOX and its isoforms have been shown to have a wide 
effect on bone and tumor development. 
In a historical background, back in the days of Hippocrates, lysyl oxidase was 
beginning to show its role in bone development. After a string of neurological issues 
plaguing the animals and some people of his city, Hippocrates wrote that the constant 
between the two groups was the Lathyrus seeds they consumed (14). Later, the condition 
would be known as lathyrism. However, lathyrism occurs in two main varieties; 
neurolathyrism and osteolathyrism, both terms coined by Selye in 1957. One variant 
affects the neurological system primarily, the other, the skeleton. However, this was not 
an isolated incident. Many occurrences throughout the 15th and up until the early 20th 
centuries were described (14). All seemed to have a common theme: a time of either low 
crop yield and or famine, which led the community to supplement their food with the 





conditions, and its resistance to blight. Yet, when these seeds would be consumed, signs 
of muscle weakness and even paralysis of the lower extremities were found, and seemed 
to affect more males than females (14, 15). These effects were seen in many animals, 
including: birds, livestock, and horses (16). Aortic lesions were common in later 
experiments involving mice (17). Therefore, considerable amounts of research were 
conducted to find the answer to these disorders. More specifically, in 1955 a handful of 
researchers isolated the substance known as 𝛃, 𝛄 L-glutamylaminopropionitrile, which is 
metabolized to 𝛃-aminopropionitrile (BAPN) (14, 17). BAPN is the natural inhibitor of 
lysyl oxidase, and is widely used today in the study of lysyl oxidase and its role in bone 
development. Therefore, lathyrism was caused by the lysyl oxidase inhibitor, BAPN 
which is concentrated in the Lathyrus Sweet Pea species of plants. Thus, early evidence 
already pointed to the importance of lysyl oxidase activity to the structure and function of 
bone and other connective tissues. 
The role LOX plays in the strength of bone cannot be understated. Such effects 
can be seen in diseases such as osteogenesis imperfecta, diabetes mellitus, chronic kidney 
disease, and osteoporosis (18, 19) . Bone structural changes leading to decreased 
integrity is heavily related to cross-linking mishaps as part of the disease process (18). 
Defects in the production or cross-linking of type 1 collagen shows significant bone 
strength reduction as well as changes in the turnover rate in patients with osteogenesis 
imperfecta (OI) (20). Microcracking seen in experimental animal models lead 
researchers to believe this is the mechanism for such an altered turnover. An increase in 





disorganization of the microarchitecture, leading to impaired strength as a result of 
altered C-telopeptide regions of type 1 collagen (19). McNerny and colleagues found a 
dose-dependent relationship between different subcutaneous concentrations of BAPN in a 
mouse model, which lead to decreased collagen cross-linking and decreased bone 
strength and fracture stiffness (21). In another recent study, Paschalis et. al. found 
decreased trabecular bone volume versus tissue ratio, decreased trabecular thickness, and 
altered collagen cross-linking in rats fed with a BAPN laced diet (22). Furthermore, they 
noted that bone mineral density distribution (BMDD) was not altered in the experimental 
rats (22). Lastly, in another BAPN lathyrism model, Oxlund and colleagues found rats 
treated with BAPN had a reduction of 45% in concentration of hydroxypyridinium 
crosslinks, a 31% decrease in bone stability toward acid attack, and significant reductions 
in breaking, bending stress, and elastic stiffness (23).  
 When it comes to bone development, there are two main classifications from 
which the skeleton is derived; that being the membranous and endochondral skeletal 
development (27). Both avenues rely on three main embryonic lineages: Neural crest 
cells, paraxial mesoderm cells, and lateral plate mesoderm cells (27). The key difference 
between the two routes is their method for how bone is produced. Membranous 
development uses osteoblasts developed from mesenchymal cells that begin to lay down 
the direct preliminary bone matrix, and endochondral first uses chondrocytes that produce 
cartilage which later ossifies into a bone network (27). Deposition is a result of cell 
condensation, a process that sees cells clustering together prior to the initiation of the 





development. Membranous developed bones are the head and collar bone structures, and 
endochondrally developed are bones of the axial skeleton and limbs (27).  
Osteoblasts are the keystone for the development and production of bone and the 
extracellular environment bone is created. Osteoblast development begins inside the bone 
marrow, where mesenchymal stem cells (MSC) are induced to begin their differentiation 
into these bone producing cells. During the differentiation, proliferation of the MSC cells 
yields a committed osteoprogenitor to become an osteoblast, and another stem cell to 
carry on the undifferentiated lineage. Key transcriptional regulators of osteoblast 
differentiation are Runx2, Osterix, ATF4, and SATB2 (29). Once the osteoblast has 
developed, proteins such as type 1 collagen, osteocalcin (OCN), and osteopontin are 
secreted to begin formation of the bone tissue (30). Osteoblasts that do not continue 
laying down osteoid fall into one of two fates, apoptosis, or they become integrated into 
the bone as osteocytes (31). However, it is important to think of bone formation and 
maintenance as a coordinated system of bone-building osteoblasts and bone-destroying 
osteoclasts. It has been found that osteoclasts are regulated by estrogen to some degree, 
and postmenopausal women who have lowered serum estrogen show increased osteoclast 
activity (29). Such activity leads to the bone disorders so often affecting this sex-age 
group such as osteoarthritis and osteoporosis, indicating that estrogen could be providing 
a protective element. Thus, elucidating the mechanisms behind osteoblast development 
and cell cycle could answer questions regarding bone disorders in our aging population.  
In order to knockout Lox in osteoblasts, we used the promoter of the osteoblast 





osteoblast Lox knockout (12).  The human osteocalcin gene is found on chromosome 1, 
1q25-q31 (4). Osteocalcin, also known as gamma-carboxyglutamic acid protein, is 
expressed in the later stages of osteoblast development and once it has undergone 
splicing, it shows an affinity for bone and the extracellular matrix (13)(32). Moreover, 
OCN has been thought to play a larger role in the mineralization process instead of a role 
in matrix deposition (32). There are two forms of OCN, the uncarboxylated form and the 
carboxylated form. Uncarboxylated OCN has been shown to be involved in insulin 
regulation with pancreatic islet cells (24, 25), and uses the Gprc6a receptor to induce its 
effects (26). Meanwhile, the carboxylated form of OCN is believed to serve a direct 
mechanical role in the bone architecture via bonding with osteopontin and integration of 
this complex into the hydroxyapatite network (4).  
In order to use the Cre-lox Recombinase system in our study, the design of the 
first floxed Lox mouse was done so using CRISPR-Cas9 technology. Since the 1980s, 
CRISPR-Cas9 (Clustered Regularly-Interspaced Short Palindromic Repeats)-Cas9 
(Crisper associated protein 9) has been a key component of molecular genetics research. 
CRISPR is able to edit genomes, providing seemingly endless avenues of study for 
potential therapeutic remedies and pathologic inquiry. The method this nuclease employs 
is the use of a 20 nucleotide RNA (gRNA) which targets the specific region in a target 
DNA (33). CRISPR finds this region and makes a cut 3 base pairs upstream of a PAM 
(Protospacer Adjacent Motif) (33). With the DNA cleaved, the DNA of interest is now 
added, allowing for the pairing with the end cut location of the host DNA. Finally, the 





or by HDR (Homology Directed Repair) and subsequent integration into the host genome 
(33). In our lab, this was done using mouse embryos that were later implanted into 
female mice, thereby creating the proper genomic sequence for future mouse studies. 
Therefore, through CRISPR technology, our lab was able to produce the first Lox-floxed 






Figure 1: Graphic representation of the genome in a homozygous lox flox mouse is 
presented. This drawing is not to scale. Diagonal black lines represent ECOR1 restriction 
enzyme cutting sites. Black filled or hollow circles represent primer set 2 and 5 binding 
sites, respectively. The sequences for Primer set 2 and 5 are as follows: Primer set 2 
forward: CTTGTGCTCCCTCTACTGGTG. Primer set 2 reverse: GATGCGCTGC 
GGAAGAAAAC. Primer set 5 forward: CGTTGCACAGGGAGAGTTAAG. Primer set 
5 reverse: TAAAGTGCAAATTGGGCTGGT. Blue rectangles with angled corners 
represent the right homology. Yellow trapezoid represents the gRNA. Black triangles 
indicate loxp binding sites. Red smooth cornered rectangles depict left homology. The 
red box indicates exon 1, whereas the green box represents exon 2. The purple lined 
trapezoid shows the gRNA target sequence. Lastly, the dashed box surrounding the 
sequences flanked by the LOX P sites show what is being excised when a lox fl/fl mouse 
is crossed with a Ocn-cre+/- mouse, giving Ocn-cre +/-, Lox fl/fl progeny. 
 
 
Analyzing phenotypic changes in the study mice will rely, in part on µCT 
imaging. µCT has been regarded as an optimal method for evaluation of mineralized 
structures (34). Furthermore, recent studies have shown soft tissue evaluation in vivo 





x-rays projected at multiple angles which pass through a series of initial collimators and 
filters prior to traversing through the sample itself (34). These x-rays are then picked up 
on a detector which integrates them into a 3D pixel known as a voxel. Voxels through 
computation algorithms are then organized into a 3D depiction of the scanned sample to 
be further investigated. The x-ray beam can be controlled at it’s source by regulation of 
the voltage and current. Most studies agree that the voltage for scanning hard tissue to be 
set at 50-70 kV while current is best set between 115-150 µA (34, 35). Similarly, voxel 
size also plays a role in the depiction of the bone structure. Voxel sizing that is too large 
or too small in regards to the source of tissue being scanned may lead to underestimation 
or overestimation of key structures (36). For scanning of smaller animals’ structures, 
such as mouse femurs, voxel size is recommended to be around 10 µm3(34, 36). A 
detailed description of the scanning parameters for the samples in this study is presented 
in the Methods section.  
Our hypothesis for the following experiment is the Ocn-cre +-, Loxfl/fl mice will 
have an altered bone phenotype in contrast to the Ocn-cre-/-, Loxfl/fl controls through µCT 
and histological analysis. We believe a change in the skeletal phenotype may occur in 
later stages of the osteoblast development due to Ocn being expressed late in the 
sequence of gene expression changes as a function of osteoblast differentiation. Thus our 
working hypothesis is that Ocn-driven conditional deletion of Lox will lead to a 






Our group employed the Cre-lox recombinase system to knockout Lox in mouse 
osteoblasts using the osteocalcin promoter to drive cre recombinase. C57BL/6J male and 
female mice were selected and bred to achieve the breeding pair genotypes Ocn-cre+/-, 
Loxfl/- and Loxfl/fl. The progeny we chose for the experimental group were Ocn-cre+/-, 
Loxfl/fl, and the control group genotypes being Ocn-cre-/-, Loxfl/fl. We analyzed the 
differences between 13-week old male and female Ocn-cre+/-, Loxfl/fl and Ocn-cre-/- 
,Loxfl/fl using µCT analysis and histological analysis. Genotyping was confirmed for each 
mouse through genomic DNA isolation from tail samples; and subsequent PCR, EcoR1 
restriction enzyme digestion, and gel electrophoresis was conducted. The primer sets of 
interest were the OCN-cre primer set, Lox primer set 2, and Lox primer set 5. Reactions 
from both primer set 2 and 5 were digested for 2 hours prior to gel electrophoresis using 
the restriction enzyme EcoR1; the Ocn-cre primer set needed no such digestion prior to 
the gel electrophoresis. 50µL of each sample was loaded into separate wells of a 1.5% 
agarose gel with 5 µL of ethidium bromide and 1x Tris/Acetate/EDTA (TAE) buffer. 110 
Volts was then applied for approximately 1 hour and 15 minutes. The gel was then placed 
over an ultraviolet light and photographed and analyzed for the DNA of interest.  
µCT analysis was carried out at the Center for Skeletal Research Imaging and 
Biomechanical Testing Core under the grant NIH P30 AR070542. 6 Female Ocn-cre-/-, 
Loxfl/fl, 6 Female Ocn-cre+/-, Loxfl/fl 6 Male Ocn-cre-/-, Loxfl/fl, and 6 Male Ocn-cre+/-, 





The following text was provided by Dr. Mary Bouxsein’s laboratory, which 
carried out the µCT analyses. “A high-resolution desktop micro-tomographic imaging 
system (µCT40, Scanco Medical AG, Brüttisellen, Switzerland) was used to assess 
trabecular bone microarchitecture in the distal femoral metaphysis, whereas cortical bone 
morphology was assessed at the femoral midshaft. Scans were acquired using a 10 µm3 
isotropic voxel size, 70 kVP, 114 mAs, 200 ms integration time, and were subjected to 
Gaussian filtration and segmentation. Image acquisition and analysis protocols adhered to 
the JBMR guidelines (1) . For the distal femur, transverse CT slices were evaluated in an 
1500 µm (150 slices) region beginning 1700 µm above the peak of the growth plate and 
extending distally to 200 µm above the top of the growth plate. The trabecular bone 
region was identified by semi-manually tracing the region of interest with the assistance 
of an auto-thresholding software algorithm. An adaptive-iterative algorithm(2-4) was 
used to select a mineral density threshold of 350 mgHA/cm3 to segment trabecular bone 
from soft tissue. Morphometric variables were computed from the binarized images using 
direct, 3D techniques that do not rely on any prior assumptions about the underlying 
structure(5-7). For trabecular bone regions, we assessed the bone volume fraction 
(BV/TV, %), trabecular thickness (Tb.Th, mm), trabecular number (Tb.N, mm-1 ), 
trabecular separation (Tb.Sp, mm), connectivity density (ConnD, 1/mm³), and structure 
model index (SMI), a parameter that describes the plate-vsrodlike nature of the 
architecture. Higher values of SMI indicate rod-like structures, whereas lower values 






“To assess cortical bone parameters, 50 transverse µCT slices were obtained at the 
femoral mid-diaphysis using a 10 µm isotropic voxel size. The ROI included the entire 
outer most edge of the cortex. Images were subjected to Gaussian filtration and 
segmented using a fixed threshold of 700 mgHA/cm3. The following variables were 
computed: total cross-sectional area (bone + medullary area) (Tt.Ar, mm2 ), cortical bone 
area (Ct.Ar, mm2 ), medullary area (Ma.Ar, mm2 ), bone area fraction (Ct.Ar/Tt.Ar, %), 
cortical tissue mineral density (Ct.TMD, mgHA/cm3 ), cortical thickness (Ct.Th, mm), 
cortical porosity (%), as well as maximum, minimum and polar moments of inertia 
(Imax, Imin, and J, mm4 ), which describe the shape/distribution of cortical bone (larger 
values indicate a higher bending strength)” (37). 
“Statistics: Unpaired t-tests were performed to compare the trabecular and cortical 
parameters of OCN-Cre- and OCN-Cre+ mice within each gender. P-values and means ± 
SD are reported” (37). 
RESULTS 
µCT analysis of the female 13-week old Ocn-cre+/-, Loxfl/fl mice showed 
statistically significant reduction in Bone Volume/Total Volume (BV/TV) (P<0.003), 
Connective Tissue Density (ConnD) (P<0.012), Bone Mineral Density (BMD) (P<0.001), 
and Structural Model Index (SMI) (P<0.004). Male 13-week old Ocn-cre+/-, Loxfl/fl mice 







Figure 2: Graphical representation of the micro-CT values of Loxfl/fl mice either 
expressing Ocn-cre+, or not (OCN-cre-, control). (From left to right, top to bottom) Bone 
Mineral Density (BMD), Bone Volume/Tidal Volume (BV/TV), Connective tissue 






Figure 3: µCT images from 13-week old female Ocn-cre+/-, Loxfl/fl and Ocn-cre-/-, 
Loxfl/fl mice showing the femoral head and mid-diaphysis regions.  
 
 
Figure 4: µCT images from 13-week old male Ocn-cre+/-, Loxfl/fl and Ocn-cre-/-, Loxfl/fl 






Histology: H&E staining of tibia sections showed a statistically significant 
decreases in the number of chondrocytes per column in the cre+ female and male mice. 




Figure 5: H&E stained sections of mice presented. Histological analysis was performed 
by Vrinda Dambal. The graph to the right side of the figure shows the number of 
chondrocytes per column observed in the histological sections. 
 
DISCUSSION 
A more significant alteration in bone parameters was expected in the osteocalcin 
promoter-driven  osteoblast knockout model. Yet, we believe this may be a result of Ocns 
rather late expression in osteoblasts (32). With this in mind, our rationale is that the role 
Lox plays in collagen crosslinking may have already be largely completed by the 13-





this may lead to a reduced, yet still significant change in BMD, BV/TV, ConnD, and SMI 
values at least in female mice at this age. Other studies have shown Lox family and 
elastin gene (Eln) activity decrease with age in female mice (38). Perhaps further time 
course studies investigating this aspect should be the next steps with this model. An 
alternative test to this hypothesis is to knockout Lox using an earlier-expressed osteoblast 
promoter, such as provided by the Col2.3-cre mouse.  
The organization of chondrocytes in the growth plate of femurs in both females 
and males were decreased. Females showed a more significant decrease as compared to 
the males. These results are similar to those found by Alsofi et. al, who looked at sex-
linked phenotype of Loxl1 global knockout mice (1). In their study, 13-week old females 
also showed disrupted chondrocyte organization compared to male counterparts, as well 
as statistically significant decreases in BV/TV and ConnD in the distal metaphysis. It is 
known that Lox expression is needed for C3H10T1/2 cell line differentiation into 
chondrocytes (3). Therefore, a possible reason for a decrease in chondrocytes seen may 
be due to secondary effects of Lox knockout in osteoblasts. Additionally, another 
possible explanation for such a change in the number of chondrocytes per column in the 
females as compared to the males may be due to estrogen’s effect on LOX. Lee et. al. 
found LOX expression was reduced when estrogen was added to an experimental 
ligament model, which also revealed decreased strength and function (7). Thus, in 
addition to the secondary effects of the Lox knockout, estrogen may have further reduced 
Lox’s chondrocyte differentiation signaling leading to decreased chondrocytes per 





by estrogen and decreased by progesterone in mouse uterus, while combined estrogen 
and progesterone delivery showed no effect (39). Elucidation of this interplay between 
Lox regulation via sex hormones needs analysis.  
CONCLUSION 
Overall, the difference in phenotype, albeit not as large as we had hoped, gives 
further insight to the role Lox plays in the overall development and homeostasis of bone. 
Clear evidence has existed for some time showing strength and microarchitectural 
changes occurring when LOX activity or other defects in type 1 collagen exist. Clinical 
implications of such defects are found in the diseases mentioned above, and their impact 
on patients is significant. Further investigation into osteoblast specific Lox knockout 
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